BIRC5 and neuroendocrine carcinoma: Interestingly, survivin knockdown reduced cell viability in NEC-DUE1 cells up to 32.4% (p < 0.001) and in NEC-DUE2 cells up to 43.9% (p < 0.001) when compared to control cells.